Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra NeuroSciences™ Launches MAYFIELD® Infinity Support System
Integra NeuroSciences(TM) Launches MAYFIELD(R) Infinity Support System PLAINSBORO, N.J., Oct. 19, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced plans to market and sell the MAYFIELD® Infinity Support System in the United States through its Integra
View HTML
Toggle Summary Integra LifeSciences and University of Pennsylvania to Present Results of Brain Tissue Oxygen Monitoring Clinical Experience at 2004 Congress of Neurological Surgeons Annual Meeting in San Francisco
Integra LifeSciences and University of Pennsylvania to Present Results of Brain Tissue Oxygen Monitoring Clinical Experience at 2004 Congress of Neurological Surgeons Annual Meeting in San Francisco PLAINSBORO, N.J., Oct. 18, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation
View HTML
Toggle Summary Integra LifeSciences Announces CE Mark for DuraGen Plus™ Adhesion Barrier Matrix
Integra LifeSciences Announces CE Mark for DuraGen Plus(TM) Adhesion Barrier Matrix PLAINSBORO, N.J., Oct. 18, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received CE Mark Certification for the DuraGen Plus™ Adhesion Barrier Matrix.
View HTML
Toggle Summary Integra NeuroSciences Launches NeuroSensor Cerebral Blood Flow and Intracranial Pressure System
Integra NeuroSciences Launches NeuroSensor Cerebral Blood Flow and Intracranial Pressure System PLAINSBORO, N.J., Oct. 15, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it plans to market and sell the NeuroSensor Cerebral Blood Flow and
View HTML
Toggle Summary Integra NeuroSciences Launches NPH™ Low Flow Hydrocephalus Valve
Integra NeuroSciences Launches NPH(TM) Low Flow Hydrocephalus Valve PLAINSBORO, N.J., Oct. 15, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced plans to market and sell the NPH™ Low Flow Hydrocephalus Valve (NPH™ Valve) through its direct Integra
View HTML
Toggle Summary Integra LifeSciences Launches INTEGRA™ Matrix Wound Dressing at Plastic Surgery 2004 in Philadelphia
Integra LifeSciences Launches INTEGRA(TM) Matrix Wound Dressing at Plastic Surgery 2004 in Philadelphia PLAINSBORO, N.J., Oct. 12, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of the INTEGRA™ Matrix Wound Dressing, a single layer version of
View HTML
Toggle Summary Integra LifeSciences Receives FDA Approval and CE Mark for INTEGRA® Dermal Regeneration Template - Terminally Sterilized
Integra LifeSciences Receives FDA Approval and CE Mark for INTEGRA(R) Dermal Regeneration Template - Terminally Sterilized PLAINSBORO, N.J., Oct. 11, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra LifeSciences has received approval from the
View HTML
Toggle Summary Integra LifeSciences Launches New Web Site For Physician Information and Training
Integra LifeSciences Launches New Web Site For Physician Information and Training PLAINSBORO, N.J., Oct. 8, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has launched a new website for physicians that provides information and training on the use
View HTML
Toggle Summary Integra LifeSciences Announces Neuromonitoring Strategic Alliance with CNS Technology, LLC and Moberg Research, Inc.
Integra LifeSciences Announces Neuromonitoring Strategic Alliance with CNS Technology, LLC and Moberg Research, Inc. PLAINSBORO, N.J., Oct. 1, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has entered into a development agreement pursuant to
View HTML
Toggle Summary Integra LifeSciences Announces Achievement of Product Development Milestone by Novus Monitoring Limited
Integra LifeSciences Announces Achievement of Product Development Milestone by Novus Monitoring Limited PLAINSBORO, N.J., Oct. 1, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it paid $1.4 million to Novus Monitoring Limited for the achievement of
View HTML
Toggle Summary District Court Awards Integra LifeSciences $6.37 Million in Damages
District Court Awards Integra LifeSciences $6.37 Million in Damages PLAINSBORO, N.J., Sept. 28, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the United States District Court for the Southern District of California, ruling in the case Integra
View HTML
Toggle Summary Integra NeuroSciences Launches NeuraWrap™ Nerve Protector
Integra NeuroSciences Launches NeuraWrap(TM) Nerve Protector PLAINSBORO, N.J., Sept. 8, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra NeuroSciences has received 510(k) clearance from the United States Food and Drug Administration to market
View HTML
Toggle Summary Integra LifeSciences Extends Employment Agreement of Chief Executive Officer
Integra LifeSciences Extends Employment Agreement of Chief Executive Officer PLAINSBORO, N.J., July 27, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Stuart M. Essig, Integra's President and Chief Executive Officer, has renewed his employment
View HTML
Toggle Summary Integra LifeSciences Announces Second Quarter 2004 Financial Results
Integra LifeSciences Announces Second Quarter 2004 Financial Results PLAINSBORO, N.J., July 27, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported net income of $7.5 million, or $0.24 per share, for the second quarter of 2004, compared to net income of $5.4
View HTML
Toggle Summary Integra LifeSciences Launches KraniOS™ Cranial Closure System
Integra LifeSciences Launches KraniOS(TM) Cranial Closure System PLAINSBORO, N.J., July 27, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it plans to market and sell the KraniOS™ Cranial Closure System, a complete set of implants and tools
View HTML